TEJWINDER DHALIWAL: Open Payments
NPI 1205142833 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 66 payments from 12 companies in 2025. Trend: 2023 $1,312 · 2024 $1,240 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $297 |
| ABBVIE INC. | 14 | $226 |
| AstraZeneca Pharmaceuticals LP | 10 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $163 |
| Lilly USA, LLC | 5 | $119 |
| Exact Sciences Corporation | 5 | $102 |
| Amgen Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| PFIZER INC. | 1 | $25 |
Products named: CAPLYTA, Ozempic, VRAYLAR, MOUNJARO, Cologuard Collection Kit, Rybelsus, BREZTRI, FARXIGA.
Industry payments across NY — which companies pay providers there.
